Skip to main content

Advertisement

SpringerLink
Log in

Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?

  • IM - Review
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

The term “vulnerable plaque” identifies atherosclerotic lesions prone to rupture. Plaque disruption facilitates the interaction of the inner components of the lesion, tissue factor (TF) among them, with the flowing blood. This results in activation of the coagulation cascade, ultimately leading to thrombus formation, and abrupt vascular occlusion. Despite the central role of vulnerable plaques in the onset of acute coronary syndromes (ACS), there are certain conditions (e.g., eroded plaques) where a hyperactive, “vulnerable” blood, may play a predominant pathophysiological role. Recently, two distinct pools of circulating TF have been identified. One, associated with cell-derived microparticles probably originating from apoptotic cells, such as macrophages, smooth muscle cells, and endothelium. The most recent, blood-borne TF, circulates in an “inactive” form (encryption) and has to be activated (decryption) to exert its thrombogenic activity. Certain pathological conditions associated with an increased rate of thrombotic complications have been associated with high levels of circulating TF. It is thought that the blood-borne TF perpetuates the initial thrombogenic stimulus, leading to the formation of larger or more stable thrombus, and thus, more severe ACS. Thus, the concept of vulnerable blood could represent a new link between the vulnerable lesion and the high-risk patient. Therefore, the assessment of selected biomarkers associated with “vulnerable or hyperreactive blood”, e.g., blood-borne tissue factor, may represent a useful tool to identify patients with a high-risk profile of developing major cardiovascular events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aikawa M, Libby P (2004) The vulnerable atherosclerotic plaque: pathogenesis, therapeutic approach. Cardiovasc Pathol 13:125–138

    Article  PubMed  Google Scholar 

  2. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ (1997) Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95(3):594–599

    CAS  PubMed  Google Scholar 

  3. Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, Bauriedel G, Lüderitz B, Fallon JT, Fuster V, Badimon JJ (2004) Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 109(16):2001–2008

    Article  CAS  PubMed  Google Scholar 

  4. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y (2003) Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9:458

    Article  CAS  PubMed  Google Scholar 

  5. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler ThrombVasc Biol 20(5):1262–1275

    CAS  Google Scholar 

  6. Nemerson Y (2002) A simple experiment and a weakening paradigm: the contribution of blood to propensity for thrombus formation. Arterioscler Thromb Vasc Biol 22(9):1369

    Article  PubMed  Google Scholar 

  7. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22):2746–2753

    Article  CAS  PubMed  Google Scholar 

  8. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ (2003) Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 107(7):973–977

    Article  CAS  PubMed  Google Scholar 

  9. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH (2001) Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 134(3):224–238

    CAS  PubMed  Google Scholar 

  10. Giesen PL, Rauch U, Bohrmann B, Kling D, Roqué M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y (1999) Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 96(5):2311–2315

    Article  CAS  PubMed  Google Scholar 

  11. Tutar E, Ozcan M, Kilickap M, Gülec S, Aras O, Pamir G, Oral D, Dandelet L, Key NS (2003) Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 108(13):1581–1584

    Article  CAS  PubMed  Google Scholar 

  12. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S (1997) Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 134(2 pt 1):253–259

    Article  CAS  PubMed  Google Scholar 

  13. Østerud B, Bjørklid E (2006) Sources of tissue factor. Semin Thromb Hemost 32(1):11–23

    Article  PubMed  Google Scholar 

  14. Lechner D, Weltermann A (2008) Circulating tissue factor-exposing microparticles. Thromb Res 122(Suppl 1):S47–S54

    Article  CAS  PubMed  Google Scholar 

  15. Rivers RP, Hathaway WE, Weston WL (1975) The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3):311–316

    Article  CAS  PubMed  Google Scholar 

  16. Maugeri N, Brambilla M, Camera M, Carbone A, Tremoli E, Donati MB, de Gaetano G, Cerletti C (2006) Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost 4(6):1323–1330

    Article  CAS  PubMed  Google Scholar 

  17. Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177(7):4794–4802

    CAS  PubMed  Google Scholar 

  18. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B (2007) Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood 109(3):995–1002

    Article  CAS  PubMed  Google Scholar 

  19. Sovershaev MA, Lind KF, Devold H, Jørgensen TØ, Hansen JB, Østerud B, Egorina EM (2008) No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils. J Thromb Haemost 6(10):1742–1749

    Article  CAS  PubMed  Google Scholar 

  20. Egorina EM, Sovershaev MA, Olsen JO, Østerud B (2008) Granulocytes do not express but acquire monocyte-derived tissue factor in whole blood: evidence for a direct transfer. Blood 111(3):1208–1216 (Epub 2007)

    Article  CAS  PubMed  Google Scholar 

  21. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlägel U, Zahler S, Engelmann B (2001) Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 281:603–609

    Article  CAS  PubMed  Google Scholar 

  22. Weyrich AS, Lindemann S, Tolley ND, Kraiss LW, Dixon DA, Mahoney TM, Prescott SP, McIntyre TM, Zimmerman GA (2004) Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 30:493–500

    Article  Google Scholar 

  23. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS (2006) Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203:2433–2440

    Article  CAS  PubMed  Google Scholar 

  24. Chargaff E, West R (1946) The biological significance of the thromboplastic protein of blood. J Biol Chem 166:189–197

    CAS  PubMed  Google Scholar 

  25. Davizon P, López JA (2009) Microparticles and thrombotic disease. Curr Opin Hematol 16(5):334–341

    Article  PubMed  Google Scholar 

  26. Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A (2009) Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 101(3):439–451

    CAS  PubMed  Google Scholar 

  27. Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, Fallon JT, Fisher EA, Schnapp LM, Nemerson Y, Taubman MB (2000) Release of active tissue factor by human arterial smooth muscle cells. Circ Res 87(2):126–132

    CAS  PubMed  Google Scholar 

  28. Baroni M, Pizzirani C, Pinotti M, Ferrari D, Adinolfi E, Calzavarini S, Caruso P, Bernardi F, Di Virgilio F (2007) Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J 21(8):1926–1933

    Article  CAS  PubMed  Google Scholar 

  29. Antoniak S, Boltzen U, Eisenreich A, Stellbaum C, Poller W, Schultheiss HP, Rauch U (2009) Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost 7(5):871–878

    Article  CAS  PubMed  Google Scholar 

  30. Hathcock J (2004) Vascular biology—the role of tissue factor. Semin Hematol 41(1 Suppl 1):30–34

    Article  CAS  PubMed  Google Scholar 

  31. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U (2005) Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 96:1233–1239

    Article  CAS  PubMed  Google Scholar 

  32. Bach RR (2006) Tissue factor encryption. Arterioscler Thromb Vasc Biol 26:456–461

    Article  CAS  PubMed  Google Scholar 

  33. Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A (1999) Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99(3):348–353

    CAS  PubMed  Google Scholar 

  34. Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. JACC 49:772–777

    CAS  PubMed  Google Scholar 

  35. Berckmans RJ, Nieuwland R, Böing AN, Romijn FP, Hack CE, Sturk A (2001) Cell derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85:639–646

    CAS  PubMed  Google Scholar 

  36. Biró E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R (2003) Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 1:2561–2568

    Article  PubMed  Google Scholar 

  37. Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie BC, Furie B (2004) Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104:3190–3197

    Article  CAS  PubMed  Google Scholar 

  38. Hrachovinová I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, Xia L, Kazazian HH Jr, Schaub RG, McEver RP, Wagner DD (2003) Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 9:1020–1025

    Article  PubMed  Google Scholar 

  39. Censarek P, Bobbe A, Grandoch M, Schrör K, Weber AA (2007) Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb Haemost 97:11–14

    CAS  PubMed  Google Scholar 

  40. Hobbs JE, Zakarija A, Cundiff DL, Doll JA, Hymen E, Cornwell M, Crawford SE, Liu N, Signaevsky M, Soff GA (2007) Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 120:S13–S21

    Article  PubMed  Google Scholar 

  41. Butenas S, Orfeo T, Mann KG (2009) Tissue factor in coagulation. Which? Where? When? Arterioscler Thromb Vasc Biol 29(12):1989–1996

    Article  CAS  PubMed  Google Scholar 

  42. Day SM, Reeve JL, Pedersen B, Farris DM, Myers DD, Im M, Wakefield TW, Mackman N, Fay WP (2005) Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105:192–198

    Article  CAS  PubMed  Google Scholar 

  43. Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG (2005) Tissue factor activity in whole blood. Blood 105:2764–2770

    Article  CAS  PubMed  Google Scholar 

  44. Balasubramanian V, Grabowski E, Bini A, Nemerson Y (2002) Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 100(8):2787–2792

    Article  CAS  PubMed  Google Scholar 

  45. Campo G, Valgimigli M, Ferraresi P, Malagutti P, Baroni M, Arcozzi C, Gemmati D, Percoco G, Parrinello G, Ferrari R, Bernardi F (2006) Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26(12):2800–2806

    Article  CAS  PubMed  Google Scholar 

  46. Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel R, Lubos E, Münzel T, Peetz D, Nicaud V, Juhan-Vague I, Tiret L, Atherogene Investigators (2007) Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study. J Thromb Haemost 5:475–482

    Article  CAS  PubMed  Google Scholar 

  47. Mälarstig A, Tenno T, Johnston N, Lagerqvist B, Axelsson T, Syvänen AC, Wallentin L, Siegbahn A (2005) Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 25(12):2667–2672

    Article  PubMed  Google Scholar 

  48. Keller TT, Choi D, Nagel C, Te Velthuis H, Gerdes VE, Wareham NJ, Bingham SA, Luben R, Hack CE, Reitsma PH, Levi M, Khaw KT, Boekholdt SM (2006) Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. J Thromb Haemost 4(11):2391–2396

    Article  CAS  PubMed  Google Scholar 

  49. Bogdanov VY, Cimmino G, Tardos JG, Tunstead JR, Badimon JJ (2009) Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost 7(5):894–897

    Article  CAS  PubMed  Google Scholar 

  50. Butenas S, Undas A, Gissel MT, Szuldrzynski K, Zmudka K, Mann KG (2008) Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 99:142–149

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Atherothrombosis Research Unit, Mount Sinai Hospital, New York, NY, USA

    Giovanni Cimmino & Juan Jose Badimon

  2. Division of Cardiology, Department of Cardio-Thoracic Sciences, Second University of Naples, Naples, Italy

    Giovanni Cimmino & Paolo Golino

  3. A. O. S. Anna e S. Sebastiano Via Tescione, 81100, Caserta, Italy

    Giovanni Cimmino & Paolo Golino

Authors
  1. Giovanni Cimmino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paolo Golino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Jose Badimon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Golino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cimmino, G., Golino, P. & Badimon, J.J. Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?. Intern Emerg Med 6, 29–34 (2011). https://doi.org/10.1007/s11739-010-0423-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-010-0423-4

Keywords

Search

Navigation